Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
National study connects higher rates of relapse in pediatric cancer patients to drug shortage, offering first example of patients hurt by shortages and renewing calls to protect patient access to lifesaving treatments. (Dr. Monika Metzger)
Scientist at St. Jude is recipient of 2012 Meyenburg Cancer Research Award. (Dr. Charles Mullighan)
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project discovery provides insight into a tough-to-cure form of acute myeloid leukemia that lays the groundwork for clinical care advances. (Dr. James Downing, Dr. Tanja Gruber)
First image from a living animal wins 2012 Nikon Small World Competition that recognizes top photomicrographs from around the world. (Dr. Michael Taylor)
St. Jude Children’s Research Hospital webcast offers childhood cancer survivors everywhere a chance to interact with experts and survivors about the risks and rewards of life after cancer. (St. Jude)
Gary M. Stephenson, former director of media relations and public affairs for Johns Hopkins Medicine, has joined St. Jude Children’s Research Hospital in Memphis, Tenn., as director of media relations.
Asha Pillai, MD, Bone Marrow Transplantation and Cellular Therapy, has been named a 2012 V Scholar in Cancer Research.
On Thursday, October 4, and Friday, October 5, some of the world’s leading cancer scientists will discuss recent advances and the future of childhood cancer, as well as other life-threatening diseases. The experts represent the full spectrum of discovery, including basic science, clinical and translational research. It’s part of St. Jude Children’s Research Hospital’s 50th year Anniversary Biomedical Symposium. (St. Jude)
At St. Jude Children’s Research Hospital, patients use beads to mark treatment milestones, from losing their hair to completing chemotherapy, in a program other hospitals could tailor to meet the needs of their patients. (St. Jude)
St. Jude Children’s Research Hospital study identifies the best test for determining treatment response in young leukemia patients, which could help guide therapy toward higher cure rate. (Dr. Hiroto Inaba)
September spotlights childhood cancer, which remains the leading cause of death by disease of young Americans. At St. Jude Children’s Research Hospital, doctors and scientists are working to change that statistic. (St. Jude)
St. Jude Children’s Research Hospital reports success using a targeted educational approach to teach young patients to remain motionless during MRI scans, making the process safer. (Dr. Jane Hankins)
St. Jude Children’s Research Hospital nurse Ed Koen is a top-10 finalist in the national competition, The Amazing Nurses Contest.
Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer. (Charles Mullighan, MD)
Work led by St. Jude Children’s Research Hospital scientists offers clues into molecular malfunction at the heart of a rare blood vessel disorder, revealing an important new regulator of cellular proteins. (Brenda Schulman, PhD)
St. Jude Children’s Research Hospital study shows how compounds blocking an enzyme universal to all influenza viruses may allow development of new antiviral drugs that also avoid the problem of drug resistance. (Dr. Stephen White)
Studies led by St. Jude Children’s Research Hospital show that a protein working on the frontlines of the immune response dampens inflammation and might offer a completely new approach to fighting bacterial infections. (Dr. Thirumala-Devi Kanneganti)
Trial led by St. Jude Children’s Research Hospital investigators succeeds in keeping cure rates high for young patients with favorable-risk Hodgkin lymphoma while reducing their chances of serious treatment side effects. (Dr. Monika Metzger)
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project lifts lid on the most aggressive subtype of medulloblastoma and finds genes that cooperate in tumor development. (Dr. Richard Gilbertson)
To speed progress against cancer and other diseases, the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project today announced the largest-ever release of comprehensive human cancer genome data for free access by the global scientific community. (Dr. James Downing)
St. Jude Children’s Research Hospital discovery that a protein vital for cell survival and immune balance has another form with a different function could yield additional cancer treatment strategy. (Dr. Joseph Opferman)
St. Jude Children's Research Hospital closes survival gap for virtually all African-American and white children with cancer in a study that suggests equal access to care translates into an equal chance of a cure. (Dr. Ching-Hon Pui)
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer. (Dr. Peter McKinnon)
Brenda Schulman, Ph.D., of St. Jude Children’s Research Hospital, has been named to the 2012 class of new Fellows and Foreign Honorary Members of the American Academy of Arts and Sciences (AAAS). Schulman was elected for her lab’s work on understanding a major form of cellular regulation, namely how ubiquitin-like proteins are conjugated to their target.
An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks of intense chemotherapy known as induction therapy. (Dr. Ching-Hon Pui)
St. Jude Children’s Research Hospital physician is the recipient of the 2012 Pediatric Oncology Award.
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project and Memorial Sloan-Kettering Cancer Center discover first gene alteration associated with patient age and neuroblastoma outcome. (Dr. Michael Dyer)
William E. Evans, Pharm.D., is the recipient of the Remington Honor Medal, the pharmacy profession’s highest recognition
St. Jude scientists discover key enzyme structure in bacteria, a finding that lays the foundation for a new generation of antibiotics that are safer and less prone to drug resistance. (Dr. Stephen White)
Drug shortages have existed for several years, but they have recently intensified. (St. Jude)
In 1962, St. Jude Children’s Research Hospital opened its doors amid an emotionally charged debate regarding how to treat childhood cancer. (St. Jude)
Results from a St. Jude Children’s Research Hospital and the Children’s Oncology Group study pinpoint genetic basis for increased leukemia risk facing Hispanic children and provide new hope for closing survival gap. (Dr. Jun Yang)
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project provides first evidence linking cancer to mutations in genes involved in DNA organization. (Dr. Suzanne Baker)
St. Jude Children’s Research Hospital has been recognized by FORTUNE magazine as one of the “100 Best Companies to Work For” for the second consecutive year. (St. Jude)
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project discovers genetic connection linking two cancers that is likely to expand treatments for patients who currently have poor prognoses. (Dr. Charles Mullighan)
Effort aims to accelerate pediatric cancer discoveries by sharing findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project. (St. Jude)
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project findings help solve mystery of retinoblastoma’s rapid growth in work that also yields a new treatment target and possible therapy. (Dr. Michael Dyer)